Tilray : Press Releases

Year

Tilray, Inc. Releases 11 Million Shares From Lock-Up Agreement

NANAIMO, British Columbia --(BUSINESS WIRE)--Mar. 31, 2020-- Tilray, Inc. (NASDAQ: TLRY) (“Tilray”), a global pioneer in cannabis production, research, cultivation and distribution, today announced that the Board of Directors of Tilray unanimously approved the pro rata release of 11 million shares

March 31, 2020

Tilray, Inc. Announces Pricing of its $90.4 Million Registered Offering

NANAIMO, British Columbia --(BUSINESS WIRE)-- Tilray, Inc. (“ Tilray” or the “Company”) (Nasdaq: TLRY), a global pioneer in cannabis production, research, cultivation and distribution, announced today that it has priced an underwritten registered offering of 7,250,000 shares of its Class 2 common

March 13, 2020

Tilray, Inc. Reports Fourth Quarter and Full Fiscal Year 2019 Financial Results

Revenue Increased 287% to $167.0 (C$217.4) Million in Full Fiscal Year 2019 Compared to the Prior Year Adult-Use Revenue Increased Over Three-Fold in the Fourth Quarter Compared to the Prior Year Period; 7% Sequential Quarterly Revenue Growth Signed and Closed $60 Million Senior Credit Facility

March 2, 2020

Tilray to Report Fourth Quarter and Full Fiscal Year 2019 Financial Results on March 2, 2020

NANAIMO, British Columbia --(BUSINESS WIRE)--Feb. 25, 2020-- Tilray Inc. (“Tilray” or the “Company”) (Nasdaq: TLRY), a global pioneer in cannabis production, research, cultivation, and distribution, announced today it will report results for the fourth quarter and full fiscal year ended December

February 25, 2020

Tilray® Expands Global Leadership Team with New COO and CFO

Former Revlon executive, Jon Levin , joins as Chief Operating Officer and former Molson Coors and Pharmaca executive, Michael Kruteck joins as Chief Financial Officer Current Tilray CFO, Mark Castaneda , to stay on in strategic business development role NANAIMO, British Columbia --(BUSINESS

January 14, 2020

Tilray, Inc. to Present at the 2020 ICR Conference

NANAIMO, British Columbia --(BUSINESS WIRE)--Jan. 7, 2020-- Tilray, Inc. , (“ Tilray” or “the Company”) (Nasdaq: TLRY), a global leader in medical cannabis research, cultivation, production and distribution, today announced that Brendan Kennedy , President and Chief Executive Officer, will present

January 7, 2020

Tilray Exports First-Ever Shipment of Medical Cannabis Allowed Into Israel

Company signs 2.5 tonne strategic partnership agreement with Canndoc to address growing demand for medical cannabis products in Israeli market Export to Israel originates from Tilray’s Portugal facility; Tilray now exports medical cannabis to 15 countries worldwide NANAIMO, British

January 2, 2020